392 related articles for article (PubMed ID: 2420897)
1. Enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to protein-reactive drugs and metabolites: criteria for identification of antibody activity. Detection and hapten specificity of anti-DNP, anti-captopril and anti-sulphanilamidobenzoic acid.
Coleman JW; Yeung JH; Tingle MD; Park BK
J Immunol Methods; 1986 Apr; 88(1):37-44. PubMed ID: 2420897
[TBL] [Abstract][Full Text] [Related]
2. Drug-protein conjugates--IX. Immunogenicity of captopril-protein conjugates.
Yeung JH; Coleman JW; Park BK
Biochem Pharmacol; 1985 Nov; 34(22):4005-12. PubMed ID: 3933517
[TBL] [Abstract][Full Text] [Related]
3. A specific enzyme-linked immunosorbent assay for definition of the IgG antibody response to disulphide-conjugated D-penicillamine in the rabbit.
Foster AL; Park BK; Coleman JW
Int Arch Allergy Appl Immunol; 1987; 84(3):271-6. PubMed ID: 3308711
[TBL] [Abstract][Full Text] [Related]
4. Drug-specific antibodies in patients receiving captopril.
Coleman JW; Yeung JH; Roberts DH; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1986 Aug; 22(2):161-5. PubMed ID: 3530304
[TBL] [Abstract][Full Text] [Related]
5. Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.
Katz DH; Paul WE; Goidl EA; Benacerraf B
J Exp Med; 1970 Aug; 132(2):261-82. PubMed ID: 4101344
[TBL] [Abstract][Full Text] [Related]
6. The immune response against hapten-autologous protein conjugates in the mouse.
Rubin B; Wigzell H
J Exp Med; 1973 Apr; 137(4):911-31. PubMed ID: 4540327
[TBL] [Abstract][Full Text] [Related]
7. Photochemical linking of primary aromatic amines to carrier proteins to elicit antibody response against the amine haptens.
Pandey RN; Davis LE; Anderson B; Hollenberg PF
J Immunol Methods; 1986 Nov; 94(1-2):237-46. PubMed ID: 3782813
[TBL] [Abstract][Full Text] [Related]
8. Drug-protein conjugates--XI. Disposition and immunogenicity of dinitrofluorobenzene, a model compound for the investigation of drugs as haptens.
Park BK; Tingle MD; Grabowski PS; Coleman JW; Kitteringham NR
Biochem Pharmacol; 1987 Mar; 36(5):591-9. PubMed ID: 3827946
[TBL] [Abstract][Full Text] [Related]
9. Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses.
Paul WE; Katz DH; Goidl EA; Benacerraf B
J Exp Med; 1970 Aug; 132(2):283-99. PubMed ID: 4101345
[TBL] [Abstract][Full Text] [Related]
10. The specificity of cellular immune responses in guinea pigs. III. The precision of antigen recognition by T lymphocytes.
Janeway CA; Paul WE
J Exp Med; 1976 Dec; 144(6):1641-56. PubMed ID: 63531
[TBL] [Abstract][Full Text] [Related]
11. Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor.
Kishimoto T; Ishizaka K
J Immunol; 1975 Feb; 114(2 Pt 1):585-91. PubMed ID: 1079034
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of biotinylated hapten-avidin complexes.
Scott D; Nitecki DE; Kindler H; Goodman JW
Mol Immunol; 1984 Nov; 21(11):1055-60. PubMed ID: 6440008
[TBL] [Abstract][Full Text] [Related]
13. Studies on immunity in hybridoma-bearing mice. A. Immune response to antigens. II. inhibition of production of anti-dinitrophenyl antibodies in mice which have rejected the B 53 anti-dinitrophenyl-producing IgE hybridoma.
Yin JZ; Furusawa S; Hirano T; Ovary Z
Int Arch Allergy Appl Immunol; 1987; 83(4):414-22. PubMed ID: 2440817
[TBL] [Abstract][Full Text] [Related]
14. Enthalpy-entropy compensation in dinitrophenyl--anti-dinitrophenyl antibody interaction(s).
Szewczuk MR; Mukkur TK
Immunology; 1977 Feb; 32(2):111-9. PubMed ID: 844891
[TBL] [Abstract][Full Text] [Related]
15. Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses.
Herzenberg LA; Tokuhisa T
J Exp Med; 1982 Jun; 155(6):1730-40. PubMed ID: 6176665
[TBL] [Abstract][Full Text] [Related]
16. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
Lee WY; Sehon AH
J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
[TBL] [Abstract][Full Text] [Related]
17. Carrier-specific recognition for induction of secretory IgA anamnestic antibody responses.
Ebersole JL; Taubman MA; Smith DJ; Frey DE
Immunology; 1987 Oct; 62(2):185-91. PubMed ID: 3679282
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cryoprecipitation of murine IgG3 anti-dinitrophenyl (DNP) monoclonal antibodies by anionic DNP-amino acid conjugates.
Spertini F; Coulie PG; Van Snick J; Davidson E; Lambert PH; Izui S
Eur J Immunol; 1989 Feb; 19(2):273-8. PubMed ID: 2495223
[TBL] [Abstract][Full Text] [Related]
19. A simple and rapid method for quantification of hapten specific antibodies.
Ghosh M; Surolia A; Bachhawat BK
J Immunol Methods; 1983 Feb; 57(1-3):295-300. PubMed ID: 6338122
[TBL] [Abstract][Full Text] [Related]
20. Experimental studies on the bridging hypothesis of anaphylaxis: haptenic determinants required to elicit immediate-type reactions in calf skin by separate or concurrent sensitization with reagins of different specificity.
Mossmann H; Meyer-Delius M; Vortisch U; Kickhöfen B; Hammer DK
J Exp Med; 1974 Dec; 140(6):1468-81. PubMed ID: 4139229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
